Patients requiring frequent ranibizumab intravitreal injections for various indications ... injections were randomly assigned to a different preparation method in each eye, and the injections ...

The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of ...

A study reveals that repeated anti-VEGF injections for AMD do not alter retinal vascular metrics over time, ensuring ...

Intravitreal injections with anti-VEGF biological treatments (anti-angiogenic therapies that target VEGF) are first-line therapy for treating and stabilizing exudative neovascular AMD (nAMD).

In this Healio Video Perspective from the Retina World Congress, Dilraj S. Grewal, MD, FASRS, provides an update on the progress of therapies for noninfectious uveitis. While some therapies failed ...

Among 41 patients treated with 8-mg aflibercept, five developed mild sterile intraocular inflammation within 1 to 3 days. All cases resolved with treatment and caused no permanent vision loss.

4D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal injection.

What can I do to prepare for a potential layoff? – Jasmyn Answer: You’re not alone ‒ many professionals feel uncertain about job stability in today’s climate, especially with news of ...

Administered as a single injection, it represents a type of treatment using lab-made proteins known as monoclonal antibodies, which can cut off your body's allergic response at its source.

RESEARCH TRIANGLE PARK, N.C. and PALO ALTO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc. ("Kriya"), a biopharmaceutical company developing gene therapies to address chronic ...